1-methyl-4-phenylpyridinium has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J; Gao, X; He, C; Liu, R; Qi, C; Sun, ZN; Wang, J; Xu, SY; Ye, ZY; You, WY; Zhang, JQ | 1 |
| Deng, X; Hu, X; Hu, Y; Huang, B; Le, W; Lei, X; Li, H; Li, J; Lü, L; Rizak, JD; Wang, J; Wang, Z; Wu, J; Xu, L; Yan, T; Yang, L; Yang, S; Zhang, B | 1 |
| Ali, SF; Duhart, HM; Newport, GD; Patterson, TA; Wang, J; Xu, Z | 1 |
3 other study(ies) available for 1-methyl-4-phenylpyridinium and Disease Exacerbation
| Article | Year |
|---|---|
The deficiency of Maged1 attenuates Parkinson's disease progression in mice.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Disease Models, Animal; Disease Progression; Dopaminergic Neurons; Humans; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Parkinson Disease; Signal Transduction | 2023 |
A quantitative approach to developing Parkinsonian monkeys (Macaca fascicularis) with intracerebroventricular 1-methyl-4-phenylpyridinium injections.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Brain; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Gait; Herbicides; Injections, Intraventricular; Macaca fascicularis; Male; Parkinsonian Disorders; Postural Balance; Severity of Illness Index; Time Factors; Tremor; Tyrosine 3-Monooxygenase | 2015 |
Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Carrier Proteins; Cell Line; Disease Progression; DNA-Binding Proteins; Dopamine; Down-Regulation; Gene Expression Regulation; Herbicides; Hypoxia-Inducible Factor-Proline Dioxygenases; Immediate-Early Proteins; Isoenzymes; L-Lactate Dehydrogenase; Membrane Proteins; Mice; Mitochondrial Proteins; Neurons; Parkinsonian Disorders; Receptors, G-Protein-Coupled; RNA, Messenger; Substantia Nigra; Thioredoxins; Time Factors | 2008 |